Breakpoints cover image

#69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition

Breakpoints

00:00

Beta D Glucan Monitoring in PEDS

The rate of IFI and true candidiasis was only 14%. 30% of the patients in the beta D glucan group didn't receive any antifungals at all. The next study also looked at biomarkers this time in PEDS or PEDS friends out there. This is interesting. All of the kids in this trial were on standard CASPA function or fluconazole per routine care for patients undergoing AML induction therapy.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app